Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use*; D001786:Blood Glucose; D001794:Blood Pressure; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D005277:Fenfluramine / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D008750:Methyldopa / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use*; D010919:Placebos; D012110:Reserpine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001067:Appetite Depressants; D001786:Blood Glucose; D006146:Guanidines; D010627:Phenethylamines; D010919:Placebos; D005461:Fluorine; D005277:Fenfluramine; D008750:Methyldopa; D012110:Reserpine; D002784:Cholesterol; D006145:Guanethidine